Marc Lippman

Marc Lippman

Directeur/Membre du Conseil chez ASCENTAGE PHARMA GROUP INTERNATIONAL

Fortune : 112 246 $ au 30/09/2026

80 ans
Health Technology
Consumer Services
Commercial Services

Profil

Marc E.
Lippman
was the founder of Ascenta Therapeutics, Inc. (founded in 2003) and held the title of Director from 2010 to 2011.
He is also the founder of Aurora Biopharma, Inc. Dr. Lippman's current job(s) include being a Director at Alphageneron Pharmaceuticals, Inc., Radiance Biopharma, Inc., and a Professor-Oncology at Georgetown Lombardi Comprehensive Cancer Center since 2018.
He is also a Member of the American Society of Clinical Oncology, Inc., the Association of American Physicians, the American Association for Cancer Research, and the American Society for Clinical Investigation.
Dr. Lippman's former job(s) include being the Chairman-Department of Medicine at The University of Miami Leonard M.
Miller School of Medicine from 2017 to 2018, an Independent Director at Seagen Inc. from 2000 to 2022, the Deputy Director at Sylvester Comprehensive Cancer Center from 2008 to 2017, and the Director of Lombardi Cancer Research Center from 1988 to 2001.
He was also a Senior Advisor at Perseus LLC and a Professor at the University of Michigan from 2001 to 2007.
Prior to that, he was the Head-Medical Breast Cancer Section at the National Cancer Institute from 1988 to 1988.
Dr. Lippman is a member of the Alpha Omega Alpha Honor Medical Society.
He received his doctorate degree from Yale University in 1968 and his undergraduate degree from Cornell University in 1964.
Dr. Lippman is also the founder of Aurora Biopharma, Inc...

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/04/2026 28 652 ( 0,01 % ) 112 246 $ 30/09/2026

Postes actifs de Marc Lippman

SociétésPosteDébut
ASCENTAGE PHARMA GROUP INTERNATIONAL Directeur/Membre du Conseil 02/01/2025
Fondateur -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur/Membre du Conseil -
Corporate Officer/Principal 01/01/2018

Anciens postes connus de Marc Lippman

SociétésPosteFin
SEAGEN INC. Directeur/Membre du Conseil 13/05/2022
░░░ ░░░░░░░░░░ ░░ ░░░░░ ░░░░░░░ ░░ ░░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Marc Lippman

Formation de Marc Lippman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

84

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées19

Finance

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Miscellaneous

Health Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Lombardi Cancer Research Center

Health Services

Health Technology

  1. Bourse
  2. Insiders
  3. Marc Lippman
🔇